Literature DB >> 26628781

Sarcomatoid carcinoma of lung - A case report and review of epidermal growth factor receptor mutation status.

Aanchal Kakkar1, Deepali Jain1, Paras Khanna2, Suryanarayana Sv Deo2, Chitra Sarkar2.   

Abstract

Entities:  

Year:  2015        PMID： 26628781      PMCID： PMC4587021          DOI： 10.4103/0970-2113.164170

Source DB:  PubMed          Journal:  Lung India        ISSN： 0970-2113


× No keyword cloud information.
  5 in total

1.  The value of biomarkers in patients with sarcomatoid carcinoma of the lung: molecular analysis of 33 cases.

Authors:  Xiangli Jiang; Yanxue Liu; Cheng Chen; Zhongli Zhan; Qingna Yan; Yuhong Guo; Qingsheng Wang; Kai Li
Journal:  Clin Lung Cancer       Date:  2011-12-13       Impact factor: 4.785

Review 2.  International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.

Authors:  William D Travis; Elisabeth Brambilla; Masayuki Noguchi; Andrew G Nicholson; Kim R Geisinger; Yasushi Yatabe; David G Beer; Charles A Powell; Gregory J Riely; Paul E Van Schil; Kavita Garg; John H M Austin; Hisao Asamura; Valerie W Rusch; Fred R Hirsch; Giorgio Scagliotti; Tetsuya Mitsudomi; Rudolf M Huber; Yuichi Ishikawa; James Jett; Montserrat Sanchez-Cespedes; Jean-Paul Sculier; Takashi Takahashi; Masahiro Tsuboi; Johan Vansteenkiste; Ignacio Wistuba; Pan-Chyr Yang; Denise Aberle; Christian Brambilla; Douglas Flieder; Wilbur Franklin; Adi Gazdar; Michael Gould; Philip Hasleton; Douglas Henderson; Bruce Johnson; David Johnson; Keith Kerr; Keiko Kuriyama; Jin Soo Lee; Vincent A Miller; Iver Petersen; Victor Roggli; Rafael Rosell; Nagahiro Saijo; Erik Thunnissen; Ming Tsao; David Yankelewitz
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

3.  EGFR and p53 status of pulmonary pleomorphic carcinoma: implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy.

Authors:  Yih-Leong Chang; Chen-Tu Wu; Jin-Yuan Shih; Yung-Chie Lee
Journal:  Ann Surg Oncol       Date:  2011-03-16       Impact factor: 5.344

4.  EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy.

Authors:  Antoine Italiano; Alexis B Cortot; Marius Ilie; Ghyslaine Martel-Planche; Thibault Fabas; Daniel Pop; Jérôme Mouroux; Veronique Hofman; Paul Hofman; Florence Pedeutour
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

Review 5.  Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors.

Authors:  A F Gazdar
Journal:  Oncogene       Date:  2009-08       Impact factor: 9.867
  5 in total
  1 in total

Review 1.  Mechanistic insights into host adaptation, virulence and epidemiology of the phytopathogen Xanthomonas.

Authors:  Shi-Qi An; Neha Potnis; Max Dow; Frank-Jörg Vorhölter; Yong-Qiang He; Anke Becker; Doron Teper; Yi Li; Nian Wang; Leonidas Bleris; Ji-Liang Tang
Journal:  FEMS Microbiol Rev       Date:  2020-01-01       Impact factor: 16.408
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.